BetterLife Pharma (BETRF) News Today → The Best AI Stock to Own in the World Today is Trading for Just $25 (From Banyan Hill Publishing) (Ad) Free BETRF Stock Alerts $0.08 -0.01 (-10.71%) (As of 05/9/2024 ET) Add Compare Share Share HeadlinesStock AnalysisChartEarningsFinancialsHeadlinesSEC FilingsShort InterestStock AnalysisChartEarningsFinancialsHeadlinesSEC FilingsShort Interest All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineBetterLife Announces Intent to Complete Private Placement of Unitsmarkets.businessinsider.com - May 3 at 9:01 PMBetterLife Announces Intent to Complete Private Placement of Unitsglobenewswire.com - May 3 at 6:00 PMBetterLife Advances BETR-001 IND-enabling Studiesfinance.yahoo.com - May 1 at 8:30 AMBloom Burton & Co. Inc.: BetterLife Pharma Inc. to Present at the 2024 Bloom Burton & Co. Healthcare Investor Conferencefinanznachrichten.de - April 15 at 8:17 AMBetterLife Announces Closing of $1.168 Million Convertible Debentures to Further Advance IND-enabling Studies of its Non-hallucinogenic LSD-based Drug Candidate BETR-001finance.yahoo.com - April 3 at 9:27 AMBetterLife’s 2-Bromo-LSD for Treatment of Depression Highlighted by Carleton Universityfinancialpost.com - March 4 at 8:04 AMBetterLife's 2-Bromo-LSD for Treatment of Depression Highlighted by Carleton Universityglobenewswire.com - March 4 at 8:00 AMBetterLife Announces Closing of a Private Placementfinance.yahoo.com - December 18 at 9:37 AMBetterLife Announces Extension of Warrantsfinance.yahoo.com - November 30 at 9:46 AMUS Patent and Trademark Office Publishes BetterLife’s Comprehensive Patent for BETR-001 and Other LSD Derivativesfinance.yahoo.com - November 15 at 8:08 AMaTyr Pharma Inc LIFEmorningstar.com - November 9 at 12:33 AMBetterLife Pharma to Host Investors Update Call on September 18, 2023finance.yahoo.com - September 14 at 9:51 AMBetterLife Obtains Favourable Animal Safety Data for Repeated Oral Dosing of BETR-001finance.yahoo.com - September 12 at 9:06 AMBetterLife Highlights BETR-001 Article in Technology Networks Drug Discovery and Announces Closing of a Private Placementfinance.yahoo.com - September 5 at 5:42 PMBetterLife Highlights American College of Physicians’ Updated Guidelines for Treating Depression and Announces Closing of Private Placementfinance.yahoo.com - July 13 at 10:10 AMBetterLife Fast Tracks Its US Patent for BETR-001 and Other LSD Derivativesfinance.yahoo.com - June 27 at 9:23 AMBetterLife To Present BETR-001 Preclinical Data at the 32nd Annual Meeting of the International Behavioural Neuroscience Society (IBNS) in Niagara Falls, Ontario, Canadafinance.yahoo.com - June 22 at 10:03 AMBetterLife's Non-Hallucinogenic LSD's Clinical Studies, Braxia's Psychedelic Treatments Continuemsn.com - June 9 at 6:57 PMBetterLife Continues Progress on BETR-001 IND-Enabling Studiesfinance.yahoo.com - June 8 at 10:45 AMBetterLife To Present BETR-001 Preclinical Data at the 2023 Annual Meeting of the Society of Biological Psychiatry (SOBP) in San Diego, Californiafinance.yahoo.com - April 25 at 1:04 PMBetterLife Pharma to Present at the 2023 Bloom Burton & Co. Healthcare Investor Conferencefinance.yahoo.com - April 24 at 8:33 AMBetterLife To Present at the 2023 Bloom Burton & Co. Healthcare Investor Conferencefinance.yahoo.com - April 20 at 10:17 AMBetterLife Pharma says BETR-001 drug candidate featured in Drug Discovery & Development articleproactiveinvestors.com - March 29 at 10:27 AMBetterLife's Non-hallucinogenic LSD (BETR-001) For Treating Mood Disorders Highlighted in Drug Discovery & Development Articlefinance.yahoo.com - March 29 at 10:27 AMPromise of BetterLife's Non-hallucinogenic LSD (BETR-001) For Treating Mood Disorders Highlighted in Medical Xpress Articlefinance.yahoo.com - March 22 at 10:40 AMCORRECTION -- BetterLife Closes $1,857,143 of Private Placementfinance.yahoo.com - March 14 at 4:20 PMBetterLife Closes $1,857,143 of Private Placementfinance.yahoo.com - March 14 at 11:19 AMPsyched: Next-Gen Compounds For Depression, Congress, Rescheduling, Benzinga Psychedelics Conference & Moremsn.com - March 13 at 8:17 PMBetterLife Files Amended and Restated Offering Document for Offering of Unitsfinance.yahoo.com - March 10 at 10:38 PMMood Disorders Could Get An Alternative Treatment With This Next-Gen, Non-Hallucinogenic Psychedelicmsn.com - March 9 at 6:13 PMBetterlife Pharma's reports positive study findings for lead candidate BETR-001proactiveinvestors.com - March 9 at 6:13 PMBetterlife Publishes Promising Results from a Study Titled “A Non-Hallucinogenic LSD Analog With Therapeutic Potential For Mood Disorders”finance.yahoo.com - March 9 at 9:00 AMBetterLife Announces Pricing of Proposed Offering of Unitsfinance.yahoo.com - March 8 at 5:58 PMBetterLife Announces Offering of Unitsfinance.yahoo.com - March 7 at 6:02 PMBetterLife Pharma hires strategic advisory services firm to support development toward clinical trials of its psychedelic compoundsproactiveinvestors.com - January 26 at 2:26 PMBetterLife Announces Engagement of Bloom Burton Securities Inc. and Provides Summary of 2022 Accomplishmentsfinance.yahoo.com - January 26 at 9:16 AMBetterLife Pharma closes private placement with help from Negev Capital to fuel clinical programsproactiveinvestors.com - December 7 at 3:58 PMBetterLife to present BETR-001 preclinical data at the American College of Neuropsychopharmacology meeting in Phoenixproactiveinvestors.com - December 2 at 12:38 PMBetterLife To Present BETR-001 Preclinical Data at the 61ST Annual Meeting of the American College of Neuropsychopharmacology (ACNP) in Phoenix, Arizonafinance.yahoo.com - December 2 at 12:38 PMPsychedelics Companies And IPs: An Extended Patent Application To Protect Multiple LSD Derivativesmsn.com - September 27 at 7:33 PMBetterLife Pharma files comprehensive patent for BETR-001 and other LSD derivativesproactiveinvestors.com - September 27 at 9:32 AMBetterLife Files Comprehensive Patent for BETR-001 and Other LSD Derivativesfinance.yahoo.com - September 27 at 9:32 AMBetterLife Pharma and collaborators to submit key joint research on BETR-001 to publicationproactiveinvestors.com - September 7 at 2:34 PMBetterLife and Collaborators to Submit Key Joint Research Publicationfinance.yahoo.com - September 7 at 8:27 AMBetterLife Pharma says new study of LSD validates the cognitive effects of its analog drug BETR-001proactiveinvestors.com - August 24 at 10:52 AMBetterLife Pharma says new study on LSD confirms the cognitive effects of its analog drug BETR-001proactiveinvestors.com - August 24 at 10:52 AMBetterLife Lead Drug (BETR-001) Promotes Structural Neural Plasticity with Possible Nootropic Effects Similar to That of LSD Without Hallucinogenic Side Effectsfinance.yahoo.com - August 24 at 10:52 AMBetterLife Pharma secures additional Mitacs funding for BETR-001 preclinical depression studiesca.proactiveinvestors.com - July 6 at 3:41 PMBetterLife's Preclinical Studies Of BETR-001 For Depression Gets Additional Sponsorship By Mitacsbenzinga.com - July 6 at 3:41 PMBetterLife Secures Additional Mitacs Funding in Collaboration with Carleton University Research Team for BETR-001 Preclinical Depression Studiesfinance.yahoo.com - July 6 at 10:10 AM Get BetterLife Pharma News Delivered to You Automatically Sign up to receive the latest news and ratings for BETRF and its competitors with MarketBeat's FREE daily newsletter. Email Address He Is Giving Away Bitcoin (Ad)And my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a very important time to pay attention to what we are doing and what is happening. If you wait... it will be too late. This week we are holding several workshops and if you attend and pay attention my special guest is going to send you $10 in Bitcoin. >> Register right here BETRF Media Mentions By Week BETRF Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. BETRF News Sentiment▼0.000.45▲Average Medical News Sentiment BETRF News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. BETRF Articles This Week▼30▲BETRF Articles Average Week Get BetterLife Pharma News Delivered to You Automatically Sign up to receive the latest news and ratings for BETRF and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: MTEM News ERNA News GHSI News ABVC News MIRA News MBRX News CMMB News ATHE News ATBPF News ELAB News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:BETRF) was last updated on 5/10/2024 by MarketBeat.com Staff From Our Partners[Webinar] A Deep Dive into Options Volatility: Skew & Relative ValueOICThis 1 Biotech Stock has been shocking the marketsHuge AlertsTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaCharles Payne Demystifies OptionsUnstoppable ProsperityForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill PublishingYou need to know these two things about AI stocks ASAP…InvestorPlaceShocking: One AI startup's revenue could surge 4,735%Manward PressBiden Nomination CANCELED?The Freeport Society Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BetterLife Pharma Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
